In the latest trading session, 1.27 million Enveric Biosciences Inc (NASDAQ:ENVB) shares changed hands as the company’s beta touched 0.75. With the company’s most recent per share price at $0.50 changing hands around $0.02 or 4.75% at last look, the market valuation stands at $4.46M. ENVB’s current price is a discount, trading about -484.0% off its 52-week high of $2.92. The share price had its 52-week low at $0.36, which suggests the last value was 28.0% up since then. When we look at Enveric Biosciences Inc’s average trading volume, we note the 10-day average is 0.15 million shares, with the 3-month average coming to 486.41K.
Enveric Biosciences Inc (NASDAQ:ENVB) trade information
Instantly ENVB is in green as seen in intraday trades today. With action 6.36%, the performance over the past five days has been green. The company’s shares are showing year-to-date downside of -61.53%, with the 5-day performance at 6.36% in the green. However, in the 30-day time frame, Enveric Biosciences Inc (NASDAQ:ENVB) is 21.38% up. Looking at the short shares, we see there were 0.19 million shares sold at short interest cover period of 0.19 days.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Enveric Biosciences Inc (ENVB) estimates and forecasts
Data shows that the Enveric Biosciences Inc share is performing relatively much better than most of its peers within the same industry. As can be gleaned from the statistics, the company’s share value shot -39.05% over the past 6 months, a 74.03% in annual growth rate that is considerably higher than the industry average of 17.10%.
Looking at the company’s year-on-year earnings, data shows that the past 5-year has an earnings growth rate of 71.22%.
ENVB Dividends
Enveric Biosciences Inc is expected to release its next quarterly earnings report on 2024-Nov-12.
Enveric Biosciences Inc (NASDAQ:ENVB)’s Major holders
If we look at who the major shareholders are, we find that insiders hold 7.72% of Enveric Biosciences Inc shares while 5.67% of the shares are in the hands of institutional holders. The share float percentage for the stock currently stands at 6.14%. There are 5.67% institutions holding the Enveric Biosciences Inc stock share, with ADVISORSHARES INVESTMENTS LLC the top institutional holder. As of 2024-06-30, the company held 7.9233% of the shares, roughly 0.32 million ENVB shares worth $0.19 million.
GEODE CAPITAL MANAGEMENT, LLC holds the second largest percentage of outstanding shares, with 1.1161% or 44659.0 shares worth $27688.0 as of 2024-06-30.
